Patents by Inventor Meital NAIM

Meital NAIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR NEUTROPHIL ROS INHIBITION
    Publication number: 20240358711
    Abstract: Methods of inhibiting reactive oxygen species production by neutrophils or treating neutrophil-mediated inflammation in a subject by contacting the neutrophils with or administering an agent selected from a cyclin dependent kinase 4 (CDK4) inhibitor, a cyclin dependent kinase 6 (CDK6) inhibitor, an epidermal growth factor receptor (EGFR) inhibitor, a proto-oncogene tyrosine-protein kinase Src (SRC) inhibitor and a sodium (Na) channel blocker are provided. Pharmaceutical compositions comprising a nanoparticle, the agent and a neutrophil targeting peptide are also provided.
    Type: Application
    Filed: July 28, 2022
    Publication date: October 31, 2024
    Applicants: IMMUNYX PHARMA LTD., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., Hadasit Medical Research Services and Development Ltd.
    Inventors: Seth Jonah SALPETER, Meital NAIM, Zvika GRANOT, Zvi Gregorio FRIDLENDER